RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for LogicBio Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for LogicBio Therapeutics Inc. is LOGC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell LogicBio Therapeutics Inc. Stock?
LogicBio Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy LogicBio Therapeutics Inc. Stock?
LogicBio Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy LogicBio Therapeutics Inc. Stock.

What's the current price of LogicBio Therapeutics Inc. Stock?
As of the end of day on the 2023-02-14, the price of an LogicBio Therapeutics Inc. (LOGC) share was $2.06.

What is the 52-week high and low for LogicBio Therapeutics Inc. Stock?
The 52-week high for LogicBio Therapeutics Inc. Stock is $2.07 and the 52-week low is $0.257.
Click to get the best stock tips daily for free!

About LogicBio Therapeutics Inc.

LogicBio Therapeutics. LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is an adeno-associated virus, which is designed to optimize gene delivery for treatments in a range of in... LOGC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT